Predicting cancer based on average telomere length is problematic
When we discuss the risk of telomere length to cancer risk, there are many studies but the conclusions we reach are limited by our simplistic assumptions.
When we discuss the risk of telomere length to cancer risk, there are many studies but the conclusions we reach are limited by our simplistic assumptions.
In this 62-minute, we have a cheerful and accessible discussion that nonetheless goes quite deeply into my Telomere/Stem Cell Theory of Aging- right down a breakdown of Koch’s Postulates (the foundation of establishing disease causation versus correlation), the nature of stem cells, and how to naturally live longer and healthier
Instead of being thrown off the the trail by the differences, we should find the commonalities. Both models of aging- oxidative damage and telomere shortening cause chromosome disruption and bone marrow mesenchymal stem cell damage and depletion.
This week, the future became the present, as scientists published a study showing that an engineered molecule that facilitates cell death could reverse signs of aging in mice and hopefully cure aging
Other than the changes in sleep, I would say one of most predictable benefits of taking adaptogens like TA-65 or Recharge is the benefit in exercise performance and recovery from injury.
Today, it was announced that the MD Anderson Cancer Center decided it had wasted $62M on askng IBM’s Watson computer to cure cancer. It is not surprising, really…a machine cannot ask questions yet, it can only answer them.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness